Evidence map›Paper›PMID 41032090›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Development of pluronic F127 and folic acid coated TiO

Kunal, Keerti Rai, Sanghamitra Pradhan, Prabhukumar Sellamuthu, Indumathi Thangavelu, Srinivas Tadepalli, Ahmed A Bhran

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

KunalDepartment of Life Sciences, Faculty of Allied Health Sciences, SGT University, Gurugram, Haryana, India.
Keerti RaiDepartment of Electrical & Electronics, ARKA JAIN University, Jamshedpur, Jharkhand, India.
Sanghamitra PradhanDepartment of Chemistry, Siksha ‛O' Anusandhan (Deemed to Be University), Bhubaneswar, Odisha, 751030, India.
Prabhukumar SellamuthuDepartment of Mechanical Engineering, Presidency University, Bengaluru, Karnataka, India.
Indumathi ThangaveluDepartment of Chemistry, CHRIST (Deemed to Be University), Bangalore, Karnataka, 560029, India.
Srinivas TadepalliDepartment of Chemical Engineering, College of Engineering, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11432, Kingdom of Saudi Arabia. stadepalli@imamu.edu.sa.
Ahmed A BhranDepartment of Chemical Engineering, College of Engineering, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11432, Kingdom of Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Functionalizing metal oxide nanoparticles with polymers and folic acid enhances eco-friendly synthesis, therapeutic efficiency, and cost-effectiveness. This study reports the green synthesis of titanium dioxide (TiO₂) and folic acid-Pluronic F127-modified TiO₂ (TiPFFA) nanoparticles using Psidium guajava leaf extract as a natural reducing and stabilizing agent. X-ray diffraction (XRD) analysis confirmed that both nanoparticles crystallized in the rutile phase. Morphological characterization by FESEM and TEM showed that the nanoparticles were spherical with uniform size distribution. FTIR spectroscopy showed Ti-O-Ti (789 cm⁻

Indexed as

Anti-Infective AgentsAntineoplastic AgentsFolic AcidMetal NanoparticlesNanoparticlesPoloxamerTitaniumAnimalsCandida albicansCell Line, TumorCell SurvivalGreen Chemistry TechnologyHumansMethicillin-Resistant Staphylococcus aureusMiceMicrobial Sensitivity TestsAnti-Infective AgentsAntineoplastic AgentsFolic AcidPlant ExtractsPoloxamerTitaniumtitanium dioxideCytotoxicityFolic acidMethicillin-resistantPluronic F127Titanium dioxide

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.